Lowering the amount of Pgp from cell surface, as in the case of R-3-treated cells, indeed relieved the inhibition on CRT, allowing the phagocytosis of cancer cells and the subsequent expansion of activated CD8+CTLs. The gene discussed is CALR; the disease is cancer.